Chinese researchers are now using seaweed sugar to tackle Alzheimer’s. Read on to learn how Oligomannate, the first treatment approved for the disease since 2003, improves cognitive function in mild to moderate Alzheimer's.
|
|
Showing posts with label Breakthroughs. Show all posts
Showing posts with label Breakthroughs. Show all posts
Tuesday, January 17
China Approves Seaweed Sugar as Alzheimer's Drug
Chinese researchers are now using seaweed sugar to tackle Alzheimer’s. Read on to learn how Oligomannate, the first treatment approved for the disease since 2003, improves cognitive function in mild to moderate Alzheimer's.
Friday, January 13
16 Years Before Alzheimer's, Blood Test Detects Symptoms
A simple experimental blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s – long before they show signs of confusion and memory loss.
Wednesday, July 13
In the Lab, Alzheimer's Gene Gets Fixed
Thursday, March 31
France Builds Alzheimer's Village
Dementia-Villages are catching on, with France building the largest one yet. At $28 million, take a quick look at the social, freedom and health advantages offered by this new angle on dementia care.
Saturday, April 3
Scientists 'Go For the Gold' When Hunting for Alzheimer's
Sunday, July 5
Can Memorable Words Test for Alzheimer's?
Sunday, May 31
NanoDevices Trap Dangerous Alzheimer's Plaque
Nanodevices are the newest weapon in medicine’s growing arsenal to fight Alzheimer’s. They capture dangerous peptides before they can assemble to form Alzheimer’s plaques in the brain. Find out how.
Sunday, October 27
A Stunning Surprise: Aducanumab Works in Trials, Heads to FDA
In March, Biogen discontinued advanced Alzheimer's trials for aducanumab, predicting it was not likely to produce meaningful benefits. Now, new data did demonstrate real benefits, the FDA will review a fresh analysis, and former trial patients are getting back on the drug. See what happened.
Subscribe to:
Posts
(
Atom
)
